At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 50 enrolled
Drug / intervention
Omecamtiv mecarbil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Single Center Double-blind, Randomized, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Omecamtiv Mecarbil in Healthy Japanese Subjects
In Brief
A Phase 1 clinical trial evaluating Omecamtiv mecarbil and Placebo for Healthy Volunteer. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of omecamtiv mecarbil in healthy volunteers in Japan.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteer
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 2015
Enrollment StartNov 2015
Primary CompletionJan 2016
TodayJul 2026
First PostedNov 10, 2015
Enrollment StartNov 13, 2015
Primary CompletionJan 6, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.6 years ago
Interventions
Omecamtiv mecarbildrug
Omecamtiv mecarbil tablets for oral administration
Placebodrug
Matching placebo tablets